logo-loader
RNS
viewCroda International PLC

Croda International - Croda completes acquisition of Avanti Polar Lipids

RNS Number : 9799V
Croda International PLC
13 August 2020
 

Press Release

13 August 2020

Croda completes acquisition of Avanti Polar Lipids

 

Croda International Plc ('Croda') today confirms that, following approval from the US regulatory authorities, it has now successfully completed the acquisition of Avanti Polar Lipids, Inc., a leader in drug delivery systems for next generation pharmaceuticals. 

 

For further information see the announcement of the acquisition signing dated 6 July 2020. 

 

 

About Croda:

Croda is the speciality chemical company that creates high performance ingredients and technologies relied upon by industries and consumers globally. More at www.croda.com.

 

Further information:

Investors: David Bishop, Croda                                              +44 7823 874428

Media: Charlie Armitstead, Teneo                                          +44 7703 330269


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ACQEAXPAFLPEEFA

Quick facts: Croda International PLC

Price: 6268

Market: LSE
Market Cap: £8.08 billion
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE